FindMyRecallSubscribe
Class I: serious health riskTerminated

Fresenius Kabi Dexmedetomidine HCl in 0 Recall

Dexmedetomidine HCl in 0

Fresenius Kabi USA, LLC · Lake Zurich, IL

Risk level
Class I
Reported by FDA
Sep 2, 2020
Recall ID
D-1537-2020
Check your lot numberHow we source this data

Summary

Fresenius Kabi recalled Dexmedetomidine HCl in 0 starting Jul 22, 2020. The FDA classified it as Class I (serious health risk) and published enforcement report D-1537-2020 on Sep 2, 2020. Reason: Cross Contamination with other products: trace amounts of lidocaine. Status: Terminated.

Why it was recalled

Cross Contamination with other products: trace amounts of lidocaine

Product description

Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg per 50 mL (4 mcg per mL), for intravenous infusion, preservative free, 50 mL Single Dose Bottle, Rx only, Fresenius Kabi Lake Zurich, IL 60047, NDC 63323-671-05

Lot numbers, UPCs & expiration codes

Lot #: 6121853, Exp 05/2021; 6122207, Exp 06/2021

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1537-2020
Classification
Class I
Status
Terminated
Recall initiated
Jul 22, 2020
FDA report date
Sep 2, 2020
Quantity
25,100 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Fresenius Kabi USA, LLC

Original FDA data

Every field from FDA enforcement report D-1537-2020, exactly as published.

Show all FDA fields
City
Lake Zurich
State
IL
Status
Terminated
Country
United States
Event ID
86095
Address
3 Corporate Dr
Code information
Lot #: 6121853, Exp 05/2021; 6122207, Exp 06/2021
Postal code
60047-8930
Report date
Sep 2, 2020
Product type
Drugs
Recall number
D-1537-2020
Classification
Class I
Recalling firm
Fresenius Kabi USA, LLC
Product quantity
25,100 bottles
Termination date
Sep 12, 2022
Reason for recall
Cross Contamination with other products: trace amounts of lidocaine
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg per 50 mL (4 mcg per mL), for intravenous infusion, preservative free, 50 mL Single Dose Bottle, Rx only, Fresenius Kabi Lake Zurich, IL 60047, NDC 63323-671-05
Distribution pattern
U.S.A. Nationwide
Recall initiation date
Jul 22, 2020
Initial firm notification
Press Release
Center classification date
Aug 21, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1537-2020, published Sep 2, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls